Minerva Neurosciences NERV
NASDAQ NERV
$2.51 -0.02 (-0.78%)
As of: Oct 21, 2026 · 10:40 AM EDT

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014)

Updated

Minerva Neurosciences' Interest Coverage Ratio came in at -10.22 for Q2 2014.

Analysis

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn -
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 25.41
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 10.28
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 7.27
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn -42.08
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn -
10 Minerva Neurosciences 117.90 Mn -130.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22
API Access

Minerva Neurosciences Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=NERV&period=max&api_key=YOUR_API_KEY